|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.56 EUR | +0.88% |
|
+7.32% | +20.39% |
| Jan. 23 | BAYER AG : JP Morgan keeps its Buy rating | ZD |
| Jan. 22 | Bayer AG - FDA grants orphan drug designation to cell therapy OPCT-001 | RE |
MarketScreener Strategies
Search
 | Bayer slows after strong recovery, valuation stretched | December 17, 2025 at 03:41 am EST |
 | Bayer benefits from Q3 earnings beat and steady outlook | November 12, 2025 at 01:03 pm EST |
 | Bayer, close to the final round(up)? | June 05, 2025 at 10:56 am EDT |
 | Bayer: A burst of pride in environment that remains very difficult | May 13, 2025 at 09:31 am EDT |
 | Roundup: Bayer ordered to pay $2.1bn to an American suffering from cancer | March 24, 2025 at 06:21 am EDT |
| Bayer AG: A balancing act | November 13, 2024 at 05:21 am EST |
 | Bayer AG: Not out of the woods yet | March 06, 2024 at 10:46 am EST |
 | Bayer AG : A difficult Sunday | November 20, 2023 at 05:47 am EST |
No results for this search
Filters
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
